Page 32 - Evercore Group News Today

CCC Information Services said on Wednesday it was going public through a merger with blank-check firm Dragoneer Growth Opportunities Corp, in a deal that valued the data and technology provider to auto and insurance firms at about $7 billion.

Operator Good morning and welcome to the Eversource Energy Fourth Quarter and Year-End 2020 Results Conference. My name is Brandon and Ill be your operator for today. [Operator Instructions]. And I will now turn it over to Jeffrey Kotkin. You may begin, sir. Jeffrey R. Kotkin -- Vice President-Investor Relations Thank you, Brandon. Good morning and thank you for joining us. Im Jeff Kotkin, Eversource Energys Vice President for Investor Relations. During this call, well be referencing slides th...

French MONTRÉAL, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nouveau Monde Graphite Inc. (“Nouveau Monde” or the “Company”) (TSXV: NOU; OTCQX: NMGRF; Frankfurt: NM9) announces that it has retained Evercore Group LLC as its financial advisor to assist with the evaluation of a potential listing of the Company’s shares in the United States (“U.S.”) on either the New York Stock Exchange (“NYSE”) or the Nasdaq Stock Market (“Nasdaq”). Arne H. Frandsen, Chairman of Nouveau Monde, stat...

PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering   PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Vor Biopharma, has an...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Vor Biopharma Announces Pricing of Initial Public Offering Vor BiopharmaFebruary 5, 2021 GMT CAMBRIDGE, Mass., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced the pricing of its initial public offering of 9,828,017 shares of ...

Share this article Share this article NEW YORK, Feb. 5, 2021 /PRNewswire/ -- CC Neuberger Principal Holdings III (the "Company") today announced that it closed its initial public offering of 40,250,000 units at $10.00 per unit, which includes the exercise in full by the underwriters of their option to purchase an additional 5,250,000 units to cover over-allotments. Total gross proceeds from the offering were $402,500,000, before deducting underwriting discounts and commissions and other of...

Share this article Share this article PASADENA, Calif., Feb. 3, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $900,000,000 aggregate principal amount of 2.000% senior notes due 2032 and $850,000,000 aggregate principal amount of 3.000% senior notes due 2051 (the "notes"). Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Everc...

CureVacs Forward-Looking Statements The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this document unless stated otherwise, and neither the delivery of this document at any time, nor any sale of securities, shall under any circumstances create an implication that the information contained herein is correct as of any time after such date or that information will be updated ...

CC Neuberger Principal Holdings III Announces Pricing of $350 Million Initial Public Offering News provided by Share this article Share this article NEW YORK, Feb. 2, 2021 /PRNewswire/ -- CC Neuberger Principal Holdings III (the "Company") today announced the pricing of its initial public offering of 35,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol "PRPC.U" beginning February 3, 2021. Each unit consists ...

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock February 02, 2021 20:51 ET | Source: Krystal Biotech, Inc. Krystal Biotech, Inc. Pittsburgh, Pennsylvania, UNITED STATES PITTSBURGH, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. (NASDAQ: KRYS) (the “Company), the leader in redosable gene therapies for rare diseases, today announced that it has priced the previously announced underwritten public offe...